CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Monterey Innovation Acquisition Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Monterey Innovation Acquisition Corp
17 State Street, 21St Floor
Phone: (917) 267-0216p:917 267-0216 NEW YORK, NY  10004  United States Fax: (302) 636-5454f:302 636-5454
This company ceased filing statements with the SEC on 12/19/2023.
This company is no longer actively traded on any major stock exchange.
Business Summary
Monterey Innovation Acquisition Corp., formerly Monterey Bio Acquisition Corp., is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its efforts on identifying a disruptive technology company.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022YesYes---

Industries
SIC Code Description
6726 Unit investment trusts, face-amount certificate offices
6770 Blank checks

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board JonasGrossman 49 3/9/2023 7/1/2020
Chief Executive Officer MuratOmur 45 3/9/2023 3/9/2023
Chief Financial Officer SeanMcgann 37 3/9/2023 3/9/2023
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 4,894,384 (As of 8/21/2023)
Shareholders: 13
Stock Exchange: NASD
Federal Tax Id: 852204842
Fax Number: (302) 636-5454
Email Address: info@montereybio.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024